[ad_1] Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune…
Tag: Prometheus Biosciences
Collecting Pharma’s Scraps Can Pay Off for This Biotech
[ad_1] Markets Heard on the Street Roivant has built a unique model that allows it to benefit from big pharma’s need to reduce R&D spending [ad_2] Source link